(Q34012525)
Statements
1 reference
FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphoma (English)
1 reference
Martin H Cohen
1 reference
John R Johnson
1 reference
Robert Justice
1 reference
Richard Pazdur
1 reference
1 June 2008
1 reference
1 reference
13
1 reference
709-714
1 reference
Identifiers
1 reference
1 reference